Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (3)
Early P 1 (3)
P 1 (1)
P 2 (2)
P 4 (2)

Trial Status

Completed7
Unknown2
Terminated1
Recruiting1
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (13)

Research Network

Activity Timeline